142 related articles for article (PubMed ID: 22799267)
1. Ultra magnetic liposomes for MR imaging, targeting, and hyperthermia.
Béalle G; Di Corato R; Kolosnjaj-Tabi J; Dupuis V; Clément O; Gazeau F; Wilhelm C; Ménager C
Langmuir; 2012 Aug; 28(32):11834-42. PubMed ID: 22799267
[TBL] [Abstract][Full Text] [Related]
2. Cancer hyperthermia using magnetic nanoparticles.
Kobayashi T
Biotechnol J; 2011 Nov; 6(11):1342-7. PubMed ID: 22069094
[TBL] [Abstract][Full Text] [Related]
3. Iron/iron oxide core/shell nanoparticles for magnetic targeting MRI and near-infrared photothermal therapy.
Zhou Z; Sun Y; Shen J; Wei J; Yu C; Kong B; Liu W; Yang H; Yang S; Wang W
Biomaterials; 2014 Aug; 35(26):7470-8. PubMed ID: 24881997
[TBL] [Abstract][Full Text] [Related]
4. Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia.
Blanco-Andujar C; Walter A; Cotin G; Bordeianu C; Mertz D; Felder-Flesch D; Begin-Colin S
Nanomedicine (Lond); 2016 Jul; 11(14):1889-910. PubMed ID: 27389703
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effect and feasibility study of hyperthermia treatment of pancreatic cancer using magnetic nanoparticles.
Wang L; Dong J; Ouyang W; Wang X; Tang J
Oncol Rep; 2012 Mar; 27(3):719-26. PubMed ID: 22134718
[TBL] [Abstract][Full Text] [Related]
6. Multi-functional liposomes showing radiofrequency-triggered release and magnetic resonance imaging for tumor multi-mechanism therapy.
Du B; Han S; Li H; Zhao F; Su X; Cao X; Zhang Z
Nanoscale; 2015 Mar; 7(12):5411-26. PubMed ID: 25731982
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle distribution and temperature elevations in prostatic tumours in mice during magnetic nanoparticle hyperthermia.
Attaluri A; Ma R; Qiu Y; Li W; Zhu L
Int J Hyperthermia; 2011; 27(5):491-502. PubMed ID: 21756046
[TBL] [Abstract][Full Text] [Related]
8. Facile synthesis of water-stable magnetite nanoparticles for clinical MRI and magnetic hyperthermia applications.
Maity D; Chandrasekharan P; Yang CT; Chuang KH; Shuter B; Xue JM; Ding J; Feng SS
Nanomedicine (Lond); 2010 Dec; 5(10):1571-84. PubMed ID: 21143034
[TBL] [Abstract][Full Text] [Related]
9. Mono-dispersed high magnetic resonance sensitive magnetite nanocluster probe for detection of nascent tumors by magnetic resonance molecular imaging.
Zhang C; Xie X; Liang S; Li M; Liu Y; Gu H
Nanomedicine; 2012 Aug; 8(6):996-1006. PubMed ID: 22197723
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility and therapeutic evaluation of magnetic liposomes designed for self-controlled cancer hyperthermia and chemotherapy.
Gogoi M; Jaiswal MK; Sarma HD; Bahadur D; Banerjee R
Integr Biol (Camb); 2017 Jun; 9(6):555-565. PubMed ID: 28513646
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects.
Ponce AM; Viglianti BL; Yu D; Yarmolenko PS; Michelich CR; Woo J; Bally MB; Dewhirst MW
J Natl Cancer Inst; 2007 Jan; 99(1):53-63. PubMed ID: 17202113
[TBL] [Abstract][Full Text] [Related]
12. Magnetic nanoparticle-induced hyperthermia treatment under magnetic resonance imaging.
Elsherbini AA; Saber M; Aggag M; El-Shahawy A; Shokier HA
Magn Reson Imaging; 2011 Feb; 29(2):272-80. PubMed ID: 21145190
[TBL] [Abstract][Full Text] [Related]
13. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.
Peller M; Schwerdt A; Hossann M; Reinl HM; Wang T; Sourbron S; Ogris M; Lindner LH
Invest Radiol; 2008 Dec; 43(12):877-92. PubMed ID: 19002060
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Hyperthermia Ablation of Tumors Using Injectable Fe₃O₄/Calcium Phosphate Cement.
Xu C; Zheng Y; Gao W; Xu J; Zuo G; Chen Y; Zhao M; Li J; Song J; Zhang N; Wang Z; Zhao H; Mei Z
ACS Appl Mater Interfaces; 2015 Jul; 7(25):13866-75. PubMed ID: 26065316
[TBL] [Abstract][Full Text] [Related]
15. On the optimal choice of the exposure conditions and the nanoparticle features in magnetic nanoparticle hyperthermia.
Bellizzi G; Bucci OM
Int J Hyperthermia; 2010; 26(4):389-403. PubMed ID: 20210609
[TBL] [Abstract][Full Text] [Related]
16. Paramagnetic dysprosium oxide nanoparticles and dysprosium hydroxide nanorods as T₂ MRI contrast agents.
Kattel K; Park JY; Xu W; Kim HG; Lee EJ; Bony BA; Heo WC; Jin S; Baeck JS; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
Biomaterials; 2012 Apr; 33(11):3254-61. PubMed ID: 22277624
[TBL] [Abstract][Full Text] [Related]
17. Water-dispersible sugar-coated iron oxide nanoparticles. An evaluation of their relaxometric and magnetic hyperthermia properties.
Lartigue L; Innocenti C; Kalaivani T; Awwad A; Sanchez Duque Mdel M; Guari Y; Larionova J; Guérin C; Montero JL; Barragan-Montero V; Arosio P; Lascialfari A; Gatteschi D; Sangregorio C
J Am Chem Soc; 2011 Jul; 133(27):10459-72. PubMed ID: 21604803
[TBL] [Abstract][Full Text] [Related]
18. Quantification and biodistribution of iron oxide nanoparticles in the primary clearance organs of mice using T
Zhang J; Ring HL; Hurley KR; Shao Q; Carlson CS; Idiyatullin D; Manuchehrabadi N; Hoopes PJ; Haynes CL; Bischof JC; Garwood M
Magn Reson Med; 2017 Aug; 78(2):702-712. PubMed ID: 27667655
[TBL] [Abstract][Full Text] [Related]
19. From the RSNA refresher courses: MR imaging in hyperthermia.
MacFall JR; Soher BJ
Radiographics; 2007; 27(6):1809-18. PubMed ID: 18025519
[TBL] [Abstract][Full Text] [Related]
20. Local delivery of magnetic resonance (MR) contrast agent in kidney using thermosensitive liposomes and MR imaging-guided local hyperthermia: a feasibility study in vivo.
Salomir R; Palussière J; Fossheim SL; Rogstad A; Wiggen UN; Grenier N; Moonen CT
J Magn Reson Imaging; 2005 Oct; 22(4):534-40. PubMed ID: 16161081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]